Role of granulocyte colony-stimulating factor in prevention and treatment of febrile neutropenia

This review presents the recent data on efficacy of using colony-stimulating factors to prevent and treat deep and febrile neutropenia. Position to use colony-stimulating factors more widely starting with chemotherapy regimens, in which the incidence of deep neutropenia is 20 %, is proved.